NEW YORK (GenomeWeb News) - Predicant Biosciences acquired San Jose, Calif.-based Pathwork Informatics with venture capital funding and renamed the company Pathwork Diagnostics, the new corporation said today.
The new company is backed with $11 million from Prospect Venture Partners, Advent Venture Partners, Novus Ventures, Venrock Associates, and Versant Ventures.
Predicant CEO Deborah Neff will be Pathwork Diagnostics' president and CEO. Glenda Anderson, founder and CEO of Pathwork Informatics, will be the new firm's chief technology officer.
The combined company's first product will be a test to help diagnose the origin of secondary and unspecified malignant cancers.
Financial details were not disclosed.